Increasing diabetes care awareness, wider insurance coverage and preference for devices that do not need finger pricks have ...

Abbott Laboratories has reported sales of $10.6bn for the third quarter (Q3) of 2024, as against $10.4bn in Q2 2024, with ...

If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Continuous monitors track blood glucose levels 24 hours a day through a sensor just under your skin, replacing finger-prick testing. They are widely funded and used overseas. The monitors alert users ...

Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report) and keeping the price ...

Recent health news highlights various topics including Abbott's profit rise due to medical device sales, Trump's IVF comments ...

AdaptHealth Corp. ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related ...

LifeSigns, in collaboration with floLIVE and Hetrogenous, proudly announces the launch of its groundbreaking Connected ...

In an era where healthcare delivery is rapidly evolving, Cooey Health has emerged as a leader in remote patient management ...

The global cardiac ambulatory monitoring market, valued at USD 13.3 billion in 2021, is set for substantial growth, with a ...

In our recent paper, “Does REDs exist?”, we raise some important questions about the REDs concept and supporting evidence (1) ...